David Michelson, MD
- 9Articles
- 24.6KReads
- 1999–2012Active
- 34Collaborators
- 64Citations
About
David Michelson, MD, has published extensively on topics including major depressive disorder, neurodevelopmental conditions, and child and adolescent psychiatry. His work encompasses clinical studies on treatments for adult attention-deficit/hyperactivity disorder, depression with associated anxiety, and the drug development process for pediatric indications. Michelson's research includes randomized controlled trials and long-term safety and efficacy analyses of medications such as atomoxetine, fluoxetine, and venlafaxine. His publications span from 1999 to 2012 in peer-reviewed journals affiliated with Psychiatrist.com.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
